Regis Doyonnas

Senior Principal Scientist & Associate Fellow - Research Pfizer

Seminars

Thursday 30th April 2026
Achieving Robust QC Standards in 3D Vascular Models to Enable Confident Preclinical Implementation
9:30 am
  • Establishing reproducible quality control protocols for 96-well 3D vascular models to ensure device readiness across multiple plates
  • Validating barrier integrity measurements in outsourced 3D vascular systems to accelerate compound screening with minimal internal development
  • Implementing scalable pre-clinical screening workflows using ready-to-use 3D models to enable rapid adoption for future therapeutic programs
Regis Doyonnas, Senior Principal Scientist & Associate Fellow - Research, Pfizer